Issues in detecting abuse of xenobiotic anabolic steroids and testosterone by analysis of athletes' urine

Clinical Chemistry

Volumn 43, Issue 7, 1997, Pages 1280-1288

  Catlin, Don H ^a,b   Hatton, Caroline K ^a   Starcevic, Sanja H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Epitestosterone; Sports medicine

Indexed keywords

EPITESTOSTERONE; STEROID; TESTOSTERONE;

ATHLETE; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOPING; DRUG RETENTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MEAN RESIDENCE TIME; STEROID METABOLISM; URINALYSIS; XENOBIOTIC METABOLISM;

EID: 0030816628     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.7.1280     Document Type: Conference Paper

References (56)

1. IOC. Medical code. Lausanne, Switzerland: International Olympic Committee, 1995; ISBN 92-9149-003-2.
2. Catlin DH, Murray TH. Performance-enhancing drugs, fair competition, and Olympic sport. JAMA 1996;276:231-7.
3. Schänzer W, Donike M. Metabolism of boldenone in man: gas chromatographic/mass spectrometric identification of urinary excreted metabolites and determination of excretion rates. Biol Mass Spectrom 1992;21:3-16.
4. Schänzer W. Metabolism of anabolic androgenic steroids [Review]. Clin Chem 1996;42:1001-20.
5. Schänzer W, Opfermann G, Donike M. Metabolism of stanozolol: identification and synthesis of urinary metabolites. J Steroid Biochem 1990;36:153-74.
6. Schänzer W, Delahaut P, Geyer H, Machnik M, Horning S. Long term detection and identification of metandienone and stanozolol abuse in athletes by gas chromatography-high-resolution mass spectrometry. J Chromatogr B 1996;687:93-108.
7. Critical issues in urinalysis of abused substances: report of the substance-abuse testing committee. Clin Chem 1988;34:605-32.
8. National Laboratory Certification Program. Guidance document for laboratories and inspectors. Washington, DC: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, 1994:123-4.
9. Schänzer W, Geyer H, Gotzmann A, Horning S, Mareck-Engelke U, Nitschke E, et al. Endogenous production and excretion of boldenone (17β-hydroxyandrosta-1,4-dien-3-one), an androgenic anabolic steroid. In: Donike M, Geyer H, Gotzmann A, et al., eds. Proc., 12th Cologne workshop on dope analysis, 10-15 April 1994. Edition Sport, Köln: Sport und Buch Strauss, 1995:199-211.
10. Daeseleire EAI, Guesquiére AD, Van Peteghem CH. Multiresidue analysis of anabolic agents in muscle tissues and urine of cattle by GC-MS. J Chromatogr Sci 1992;30:409-14.
11. Debruyckere G, de Sagher R, Van Peteghem C. Clostebol-positive urine after consumption of contaminated meat. Clin Chem 1992; 38:1869-73.
12. Bjorkhem I, Ek H. Detection and quantitation of 19-norandrosterone in urine by isotope dilution-mass spectrometry. J Steroid Biochem 1982;17:447-51.
13. Debruyckere G, Van Peteghem CH. Influence of the consumption of meat contaminated with anabolic steroids on doping tests. Anal Chim Acta 1993;275:49-56.
14. Hemmersbach P, Tomten S, Nilsson S, Oftebro H, Havrevoll O, Oen B, Birkeland K. Illegal use of anabolic agents in animal fattening - consequences for doping control. In: Donike M, Geyer H, Gotzmann A, et al., eds. Proc., 12th Cologne workshop on dope analysis, 10-15 April 1994. Edition Sport, Köln: Sport und Buch Strauss, 1995:185-92.
15. Kicman AT, Cowan DA, Myhre L, Nilsson S, Tomten S, Oftebro H. Effect on sports drug tests of ingesting meat from steroid (methenolone)-treated livestock. Clin Chem 1994;40:2084-7.
16. 14C-testosterone in human subjects. I. Distribution in bile, blood, feces and urine. J Clin Invest 1956;35:1331-9.
17. 14C]testosterone: influence of age. Acta Endocrinol (Copenh) 1981;96:265-72.
18. Brooks RV, Jeremiah G, Webb WA, Wheeler M. Detection of anabolic steroid administration to athletes. J Steroid Biochem 1979;11:913-7.
19. Kicman AT, Brooks RV, Collyer SC, Cowan DA, Nanjee MN, Southan GJ, et al. Criteria to indicate testosterone administration. Br J Sports Med 1990;24:253-64.
20. Carlström K, Palonek E, Garle M, Oftebro H, Stanghelle J, Björkhem I. Detection of testosterone administration by increased ratio between serum concentrations of testosterone and 17α-hydroxyprogesterone. Clin Chem 1992;38:1779-84.
21. Ziegler JB. Introduction. In: Goldman B, ed. Death in the locker room. South Bend, IN: Icarus Press, 1984:1-3.
22. Donike M, Barwald KR, Klostermann K, Schänzer W, Zimmermann J. Nachweis von exogenem Testosteron [Detection of exogenous testosterone]. In: Heck H, Hollmann W, Liesen H, et al., eds. Sport: Leistung und Gesundheit, Kongressbd. Dtsch Sportarztekongress. Köln: Deutscher Ärzte-Verlag, 1983:293-8.
23. Korenman SG, Wilson H, Lipsett MB. Isolation of 17-alpha-hydroxyandrost-4-en-3-one (epitestosterone) from human urine. J Biol Chem 1964;239:1004-6.
24. Dehennin L, Matsumoto AM. Long-term administration of testosterone enanthate to normal men: alterations of the urinary profile of androgen metabolites potentially useful for detection of testosterone misuse in sport. J Steroid Biochem Mol Biol 1993;44: 179-89.
25. Namba O, Miyachi Y, Kawahara M, Kuroda I, Kuroda Y. Urinary testosterone and epitestosterone secretion in a doping positive subject. In: Laron Z, Rogol AD, eds. Hormones and sport. New York: Raven Press, Serono Symposia Publications, 1989:275-83.
26. Oftebro H. Evaluating an abnormal urinary steroid profile. Lancet 1992;339:941-2.
27. Kicman AT, Oftebro H, Walker C, Norman N, Cowan DA. Potential use of ketoconazole in a dynamic endocrine test to differentiate between biological outliers and testosterone use by athletes. Clin Chem 1993;39:1798-803.
28. Raynaud E, Audran M, Brun JF, Fedou C, Chanal JL, Orsetti A. False-positive cases in detection of testosterone doping. Lancet 1992;340:1468-9.
29. Garle M, Ocka R, Palonek E, Björkhem I. Increased urinary testosterone/epitestosterone ratios found in Swedish athletes in connection with a national control program evaluation of 28 cases. J Chromatogr B 1996;687:55-9.
30. Baenziger J, Bowers L. Variability of T/E ratios in athletes. In: Donike M, Geyer H, Gotzmann A, et al., eds. Proc., 11th Cologne workshop on dope analysis, 7-12 March 1993. Edition Sport, Köln: Sport und Buch Strauss, 1994, 41-52.
31. Catlin DH. Androgen abuse by athletes. In: Bhasin S, Gabelnick HL, Spieler JM, Swerdloff RS, Wang C, Kelly C, eds. International Androgen Workshop (2nd): pharmacology, biology, and clinical applications of androgens: current status and future prospects. New York: Wiley-Liss, 1995:289-300.
32. Donike M, Rauth S, Mareck-Engelke U, Geyer H, Nitschke R. Evaluation of longitudinal studies, the determination of subject based reference ranges of the testosterone/epitestosterone ratio. In: Donike M, Geyer H, Gotzmann A, et al., eds. Proc., 11th Cologne workshop on dope analysis, 7-12 March 1993. Edition Sport, Köln: Sport und Buch Strauss, 1994:33-9.
33. Mareck-Engelke U, Flenker U, Donike M. Stability of steroid profiles (5): the annual rhythm of urinary ratios and excretion rates of endogenous steroids in female and its menstrual dependency. In: Donike M, Geyer H, Gotzmann A, et al., eds. Proc., 13th Cologne workshop on dope analysis, 12-17 April 1995. Edition Sport, Köln: Sport und Buch Strauss, 1996:177-90.
34. Geyer H, Schänzer W, Mareck-Engelke U, Donike M. Factors influencing the steroid profile. In: Donike M, Geyer H, Gotzmann A, et al., eds. Proc., 13th Cologne workshop on dope analysis, 12-17 April 1995. Edition Sport, Köln: Sport und Buch Strauss, 1996:95-114.
35. Linnet K. Effect of the biological matrix on the urinary testosterone/epitestosterone ratio measured by gas chromatography/ mass spectrometry in doping analysis. Biol Mass Spectrom 1993;22:412-8.
36. Catlin DH, Cowan DA, de la Torre R, Donike M, Fraisse D, Oftebro H, et al. Urinary testosterone (T) to epitestosterone (E) ratios by GC/MS. I. Initial comparison of uncorrected T/E in six international laboratories. J Mass Spectrom 1996;31:397-402.
37. Nolteernsting E, Geyer H, Mareck-Engelke U, Schänzer W, Donike M. Standardization of the T/E determination by deuterated internal standards. In: Donike M, Geyer H, Gotzmann A, et al., eds. Proc., 12th Cologne workshop on dope analysis, 10-15 April 1994. Edition Sport, Köln: Sport und Buch Strauss, 1995:113-20.
38. Boeniger MF, Lowry LK, Rosenberg J. Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: a review. Am Ind Hyg Assoc J 1993;54: 615-27.
39. Weykamp CW, Penders TJ, Schmidt NA, Borburgh AJ, van de Calseyde KF, Wolthers BJ. Steroid profile for urine: reference values. Clin Chem 1989;35:2281-4.
40. Oftebro H, Jensen J, Mowinckel P, Norli HR. Establishing a ketoconazole suppression test for verifying testosterone administration in the doping control of athletes. J Clin Endocrinol Metab 1994;78:973-7.
41. Dehennin L. On the origin of physiologically high ratios of urinary testosterone to epitestosterone: consequences for reliable detection of testosterone administration by male athletes. J Endocrinol 1994;142:353-60.
42. Dehennin L. Detection of simultaneous self-administration of testosterone and epitestosterone in healthy men. Clin Chem 1994;40:106-9.
43. 3]-testosterone, -epitestosterone and their glucuronides and sulfates. J Steroid Biochem Mol Biol 1996;58:225-34.
44. Becchi M, Aguilera R, Farizon Y, Flament MM, Casabianca H, James P. Gas chromatography/combustion/isotope-ratio mass spectrometry analysis of urinary steroids to detect misuse of testosterone in sport. Rapid Commun Mass Spectrom 1994;8: 304-8.
45. Aguilera R, Becchi M, Casabianca H, Hatton CK, Catlin DH, Starcevic B, et al. Improved method of detection of testosterone abuse by gas chromatography/combustion/isotope ratio mass spectrometry analysis of urinary steroids. J Mass Spectrom 1996;31:169-76.
46. Falk O, Palonek E, Björkhem I. Effect of ethanol on the ratio between testosterone and epitestosterone in urine. Clin Chem 1988;34:1462-4.
47. Mareck-Engelke U, Geyer H, Schindler U, Flenker U, Iffland R, Donike M. Influence of ethanol on steroid profile parameters. In: Donike M, Geyer H, Gotzmann A, et al., eds. Proc., 13th Cologne workshop on dope analysis. Köln: Sport und Buch Strauss, 1995:144-8.
48. Seppenwoolde-Waasdorp TJA, de Boar D, Van Engelen HMJ, Vrijday AD, Maes RAAA. Evaluation of endogenous steroid profiles in urine. 2. Effects of ethanol intake revisited. In: Donike M, Geyer H, Gotzmann A, et al., eds. Proc., 13th Cologne workshop on dope analysis. Köln: Sport und Buch Strauss, 1995:157-65.
49. Leinonen A, Karila T, Seppälä T. An increased testosterone to epitestosterone ratio due to high doses of ethanol - a case report on a female powerlifter. In: Donike M, Geyer H, Gotzmann A, et al., eds. Proc., 13th Cologne workshop on dope analysis. Köln: Sport und Buch Strauss, 1995:167-76.
50. Hatton CK, Catlin DH, Straus PW, Starcevic SH. Urinary steroid profiles: a longitudinal study. Proc., 38th ASMS Conf. on Mass Spectrometry and Allied Topics, Tucson, AZ, June 3-8, 1990: 1004-5.
51. Mareck-Engelke U, Geyer H, Donike M. Stability of steroid profiles (4): the circadian rhythm of urinary ratios and excretion rates of endogenous steroids in female and its menstrual dependency. In: Donike M, Geyer H, Gotzmann A, et al., eds. Proc., 12th Cologne workshop on dope analysis, 10-15 April 1994. Edition Sport, Köln: Sport und Buch Strauss, 1995:135-55.
52. Salehian B, Wang C, Alexander G, Davidson T, McDonald V, Berman N, et al. Pharmacokinetics, bioefficacy, and safety of sublingual testosterone cyclodextrin in hypogonadal men: comparison to testosterone enanthate - a clinical research center study. J Clin Endocrinol Metab 1995;80:3567-75.
53. Cunningham GR, Cordero E, Thornby JI. Testosterone replacement with transdermal therapeutic systems. Physiological serum testosterone and elevated dihydrotestosterone levels. JAMA 1989; 261:2525-30.
54. Meikle AW, Arver S, Dobs AS, Sanders SW, Rajaram L, Mazer NA. Pharmacokinetics and metabolism of a permeation-enhanced testosterone transdermal system in hypogonadal men: influence of application site - a clinical research center study. J Clin Endocrinol Metab 1996;81:1832-40.
55. Catlin DH, Salehian B, Boghosian T, Swerdloff RS, Wang C. Changes in urinary testosterone and epitestosterone after sublingual testosterone cyclodextrin administration [Abstract]. Clin Res 1993;42:74A.
56. Bhasin S, Storer TW, Berman N, Callegari C, Clevenger B, Phillips J, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 1996;335: 1-7.